The diabetes and weight loss drug semaglutide is a popular and powerful treatment option. While the injectable forms, Ozempic and Wegovy, have gotten plenty of coverage, theres been much less hype for ...

Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and ...

It’s frustrating to watch, given my field of study.

Brianna believes Ozempic has a devastating side effect. The post Brianna Chickenfry Has Deadly Warning for Ozempic Users ...

Novo Nordisk said Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the FDA has approved ...

Novo Nordisk (NVO) on Wednesday announced plans to launch some doses of its oral GLP-1 receptor agonist semaglutide under the brand name Ozempic pill in Q2 2026, following a successful commercial ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be ...

The Danish drugmaker said it plans to offer the medicines for $675 per month starting in January 2027, representing a 50% ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have reported digestive issues while taking the medications, including nausea, ...

An experimental weight loss GLP-1 drug CagriSema is being touted as a better weight loss drug. Doctors say there's still one ...

On Monday morning, Novo Nordisk, the makers of the GLP-1 drug semaglutide (Ozempic and Wegovy), and Hims & Hers Health Inc.

Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years of study. The ...